In Silico Prospecting for Novel Bioactive Peptides from Seafoods: A Case Study on Pacific Oyster (Crassostrea gigas)

Pacific oyster (Crassostrea gigas), an abundant bivalve consumed across the Pacific, is known to possess a wide range of bioactivities. While there has been some work on its bioactive hydrolysates, the discovery of bioactive peptides (BAPs) remains limited due to the resource-intensive nature of the...

Full description

Bibliographic Details
Published in:Molecules
Main Authors: Leyi Zhou, Rufa L. Mendez, Jung Yeon Kwon
Format: Text
Language:English
Published: Multidisciplinary Digital Publishing Institute 2023
Subjects:
Online Access:https://doi.org/10.3390/molecules28020651
id ftmdpi:oai:mdpi.com:/1420-3049/28/2/651/
record_format openpolar
spelling ftmdpi:oai:mdpi.com:/1420-3049/28/2/651/ 2023-08-20T04:06:01+02:00 In Silico Prospecting for Novel Bioactive Peptides from Seafoods: A Case Study on Pacific Oyster (Crassostrea gigas) Leyi Zhou Rufa L. Mendez Jung Yeon Kwon agris 2023-01-09 application/pdf https://doi.org/10.3390/molecules28020651 EN eng Multidisciplinary Digital Publishing Institute https://dx.doi.org/10.3390/molecules28020651 https://creativecommons.org/licenses/by/4.0/ Molecules; Volume 28; Issue 2; Pages: 651 in silico prospecting bioactive peptides seafood Crassostrea gigas oyster proteins Text 2023 ftmdpi https://doi.org/10.3390/molecules28020651 2023-08-01T08:11:40Z Pacific oyster (Crassostrea gigas), an abundant bivalve consumed across the Pacific, is known to possess a wide range of bioactivities. While there has been some work on its bioactive hydrolysates, the discovery of bioactive peptides (BAPs) remains limited due to the resource-intensive nature of the existing discovery pipeline. To overcome this constraint, in silico-based prospecting is employed to accelerate BAP discovery. Major oyster proteins were digested virtually under a simulated gastrointestinal condition to generate virtual peptide products that were screened against existing databases for peptide bioactivities, toxicity, bitterness, stability in the intestine and in the blood, and novelty. Five peptide candidates were shortlisted showing antidiabetic, anti-inflammatory, antihypertensive, antimicrobial, and anticancer potential. By employing this approach, oyster BAPs were identified at a faster rate, with a wider applicability reach. With the growing market for peptide-based nutraceuticals, this provides an efficient workflow for candidate scouting and end-use investigation for targeted functional product preparation. Text Crassostrea gigas Pacific oyster MDPI Open Access Publishing Pacific Molecules 28 2 651
institution Open Polar
collection MDPI Open Access Publishing
op_collection_id ftmdpi
language English
topic in silico prospecting
bioactive peptides
seafood
Crassostrea gigas
oyster proteins
spellingShingle in silico prospecting
bioactive peptides
seafood
Crassostrea gigas
oyster proteins
Leyi Zhou
Rufa L. Mendez
Jung Yeon Kwon
In Silico Prospecting for Novel Bioactive Peptides from Seafoods: A Case Study on Pacific Oyster (Crassostrea gigas)
topic_facet in silico prospecting
bioactive peptides
seafood
Crassostrea gigas
oyster proteins
description Pacific oyster (Crassostrea gigas), an abundant bivalve consumed across the Pacific, is known to possess a wide range of bioactivities. While there has been some work on its bioactive hydrolysates, the discovery of bioactive peptides (BAPs) remains limited due to the resource-intensive nature of the existing discovery pipeline. To overcome this constraint, in silico-based prospecting is employed to accelerate BAP discovery. Major oyster proteins were digested virtually under a simulated gastrointestinal condition to generate virtual peptide products that were screened against existing databases for peptide bioactivities, toxicity, bitterness, stability in the intestine and in the blood, and novelty. Five peptide candidates were shortlisted showing antidiabetic, anti-inflammatory, antihypertensive, antimicrobial, and anticancer potential. By employing this approach, oyster BAPs were identified at a faster rate, with a wider applicability reach. With the growing market for peptide-based nutraceuticals, this provides an efficient workflow for candidate scouting and end-use investigation for targeted functional product preparation.
format Text
author Leyi Zhou
Rufa L. Mendez
Jung Yeon Kwon
author_facet Leyi Zhou
Rufa L. Mendez
Jung Yeon Kwon
author_sort Leyi Zhou
title In Silico Prospecting for Novel Bioactive Peptides from Seafoods: A Case Study on Pacific Oyster (Crassostrea gigas)
title_short In Silico Prospecting for Novel Bioactive Peptides from Seafoods: A Case Study on Pacific Oyster (Crassostrea gigas)
title_full In Silico Prospecting for Novel Bioactive Peptides from Seafoods: A Case Study on Pacific Oyster (Crassostrea gigas)
title_fullStr In Silico Prospecting for Novel Bioactive Peptides from Seafoods: A Case Study on Pacific Oyster (Crassostrea gigas)
title_full_unstemmed In Silico Prospecting for Novel Bioactive Peptides from Seafoods: A Case Study on Pacific Oyster (Crassostrea gigas)
title_sort in silico prospecting for novel bioactive peptides from seafoods: a case study on pacific oyster (crassostrea gigas)
publisher Multidisciplinary Digital Publishing Institute
publishDate 2023
url https://doi.org/10.3390/molecules28020651
op_coverage agris
geographic Pacific
geographic_facet Pacific
genre Crassostrea gigas
Pacific oyster
genre_facet Crassostrea gigas
Pacific oyster
op_source Molecules; Volume 28; Issue 2; Pages: 651
op_relation https://dx.doi.org/10.3390/molecules28020651
op_rights https://creativecommons.org/licenses/by/4.0/
op_doi https://doi.org/10.3390/molecules28020651
container_title Molecules
container_volume 28
container_issue 2
container_start_page 651
_version_ 1774716916173111296